Bevacizumab With or Without TRC105 in Treating Patients With Metastatic Kidney Cancer

Clinical trial NCT01727089 · COMPLETED

Trial details

NCT number: NCT01727089
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Clear Cell Renal Cell Carcinoma Recurrent Renal Cell Carcinoma Stage IV Renal Cell Cancer Type 1 Papillary Renal Cell Carcinoma Type 2 Papillary Renal Cell Carcinoma

Start date: 2012-11-01
Primary completion: 2017-08-08
Enrollment: 59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.